tiprankstipranks
Intellia Therapeutics (DE:38I)
FRANKFURT:38I
Want to see DE:38I full AI Analyst Report?

Compare Intellia Therapeutics (38I) vs. Competitors

13 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Intellia Therapeutics
€11.70
€1.38B
-2.54
90.55%
9 Buy
7 Hold
2 Sell
Moderate Buy
Kura Oncology
$9.68
$827.27M
-2.82
65.10%
9 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$6.00
$325.96M
-13.46
2.84%
11 Buy
1 Hold
0 Sell
Strong Buy
AbCellera Biologics
$4.01
$1.46B
-28.55
139.80%
6 Buy
0 Hold
0 Sell
Strong Buy
Janux Therapeutics Inc
$15.82
$884.49M
-8.94
-43.42%
13 Buy
1 Hold
1 Sell
Strong Buy
Bicara Therapeutics Inc.
$24.01
$1.51B
-6.21
94.20%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:38I
Intellia Therapeutics
12.10
4.75
64.58%
KURA
Kura Oncology
9.32
3.32
55.33%
CMPX
Compass Therapeutics
1.81
0.03
1.69%
ABCL
AbCellera Biologics
4.82
2.81
139.80%
JANX
Janux Therapeutics Inc
14.54
-11.83
-44.86%
BCAX
Bicara Therapeutics Inc.
23.09
9.96
75.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts